ATE1281T1 - Insulinkristallsuspension und verfahren zu ihrer herstellung. - Google Patents

Insulinkristallsuspension und verfahren zu ihrer herstellung.

Info

Publication number
ATE1281T1
ATE1281T1 AT80104879T AT80104879T ATE1281T1 AT E1281 T1 ATE1281 T1 AT E1281T1 AT 80104879 T AT80104879 T AT 80104879T AT 80104879 T AT80104879 T AT 80104879T AT E1281 T1 ATE1281 T1 AT E1281T1
Authority
AT
Austria
Prior art keywords
production
crystal suspension
crystals
insulin crystal
insulin
Prior art date
Application number
AT80104879T
Other languages
German (de)
English (en)
Inventor
Horst Dr. Thurow
Original Assignee
Hoechst Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Aktiengesellschaft filed Critical Hoechst Aktiengesellschaft
Application granted granted Critical
Publication of ATE1281T1 publication Critical patent/ATE1281T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C07K14/625—Extraction from natural sources

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
AT80104879T 1979-08-22 1980-08-16 Insulinkristallsuspension und verfahren zu ihrer herstellung. ATE1281T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19792933946 DE2933946A1 (de) 1979-08-22 1979-08-22 Insulinkristallsuspension und verfahren zu ihrer herstellung.
EP80104879A EP0025868B1 (de) 1979-08-22 1980-08-16 Insulinkristallsuspension und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE1281T1 true ATE1281T1 (de) 1982-07-15

Family

ID=6079022

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80104879T ATE1281T1 (de) 1979-08-22 1980-08-16 Insulinkristallsuspension und verfahren zu ihrer herstellung.

Country Status (12)

Country Link
EP (1) EP0025868B1 (en, 2012)
JP (1) JPS5632412A (en, 2012)
AT (1) ATE1281T1 (en, 2012)
AU (1) AU539091B2 (en, 2012)
CA (1) CA1155439A (en, 2012)
DE (2) DE2933946A1 (en, 2012)
DK (1) DK149347C (en, 2012)
ES (1) ES494260A0 (en, 2012)
GR (1) GR69915B (en, 2012)
IE (1) IE50188B1 (en, 2012)
IL (1) IL60889A (en, 2012)
ZA (1) ZA805152B (en, 2012)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534488A (en) * 1993-08-13 1996-07-09 Eli Lilly And Company Insulin formulation
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US5504188A (en) * 1994-06-16 1996-04-02 Eli Lilly And Company Preparation of stable zinc insulin analog crystals
YU18596A (sh) * 1995-03-31 1998-07-10 Eli Lilly And Company Analogne formulacije monomernog insulina
EP0840748B1 (en) 1995-07-25 2003-04-09 Novartis AG Transforming growth factor beta crystals
ATE219942T1 (de) * 1997-03-20 2002-07-15 Novo Nordisk As Therapeutische pulverformulierung zur pulmonaren anwendung, welche kristallines insulin enthält
DE102009001969A1 (de) 2009-03-30 2010-10-07 Robert Bosch Gmbh Sensormodul
WO2020144606A1 (en) * 2019-01-10 2020-07-16 Biocon Limited Preparative crystallization of recombinant human insulin

Also Published As

Publication number Publication date
DE3060628D1 (en) 1982-08-19
DK359380A (da) 1981-02-23
IE50188B1 (en) 1986-03-05
GR69915B (en, 2012) 1982-07-21
DK149347C (da) 1986-10-20
IL60889A0 (en) 1980-10-26
IE801762L (en) 1981-03-22
ES8205752A1 (es) 1982-08-01
ZA805152B (en) 1981-08-26
EP0025868B1 (de) 1982-06-30
EP0025868A1 (de) 1981-04-01
CA1155439A (en) 1983-10-18
IL60889A (en) 1983-07-31
AU6162180A (en) 1981-04-09
JPS5632412A (en) 1981-04-01
AU539091B2 (en) 1984-09-13
DK149347B (da) 1986-05-12
DE2933946A1 (de) 1981-03-12
ES494260A0 (es) 1982-08-01

Similar Documents

Publication Publication Date Title
DE69105752D1 (de) Verfahren zur herstellung von florfenicol, seine analoga und oxazolinzwischenprodukte.
HU908495D0 (en) Process for the production of a-nor-steroid-3-carbonic acid derivatives
DE3680800D1 (de) Verfahren zur herstellung von (6r)-tetrahydro-l-biopterin.
ATE52500T1 (de) Cyclohexenol-derivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses.
PT66099A (fr) Procede de preparation de nouvelles oximes derivees de i'acide 7-amino thiazolyl acetamido cephalosporanique
ATE1281T1 (de) Insulinkristallsuspension und verfahren zu ihrer herstellung.
ATE32071T1 (de) Cyclohexenonderivate, verfahren zu ihrer herstellung sowie ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses.
ATE47141T1 (de) Sulfat von 5,6,7,8-tetrahydro-l-erythro-biopterin und verfahren zu seiner herstellung.
ATE105560T1 (de) Verfahren zur herstellung von kristallinem cefadroxilmonohydrat.
GB1520160A (en) Process for producing sodium fluoride from sodium silicofluoride
ATE19058T1 (de) Substituierte hydroxymalonsaeurediamide, verfahren zu ihrer herstellung sowie ihre verwendung als schaedlingsbekaempfungsmittel.
ATE14577T1 (de) Harnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses.
ATE116322T1 (de) Kristallines cefadroxil und verfahren zu dessen herstellung.
PT84467A (en) Process for preparing 1-phenylimidazolcarbonic acid amides and of growth plant regulators containing the same
PT66944B (fr) Procede de preparation de nouvelles oximes derivees de l'acide 3-carbamoyloxymethyl 7-amino thiazolyl acetamido cephalosporanique
ATE78257T1 (de) Im wesentlichen wasserfreies kristallines cefadroxil und verfahren zu dessen herstellung.
ATE56963T1 (de) Verfahren zur herstellung von aminothiazolessigsaeurederivaten.
JPS6483519A (en) Production of basic crystallized zirconia-based sol
ES8506689A1 (es) Procedimiento para la obtencion de esteres de acido cumalico
SU1681500A1 (ru) СПОСОБ ПОЛУЧЕНИЯ П-ЗАМЕЩЕННЫХ α -ФЕНОКСИПРОПИОНОВОЙ КИСЛОТЫ
YU48127B (sh) Postupak za dobijanje acil-ureido derivata d-(-)-alfa-aminobenzilpenicilina i njihovih farmaceutski prihvatljivih soli
KR830003214A (ko) 인슐린 결정 현탁액 및 그의 제조방법
RU93016328A (ru) СПОСОБ ПОЛУЧЕНИЯ РАВНОМЕРНО ИЗОТОПОМОДИФИЦИРОВАННЫХ ПРИРОДНЫХ L- α -АМИНОКИСЛОТ И ПРИРОДНЫЕ L- a -АМИНОКИСЛОТЫ, РАВНОМЕРНО МОДИФИЦИРОВАННЫЕ ИЗОТОПОМ *991*993С ИЛИ ИЗОТОПАМИ *991*993С И *991*995N

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee